Adjuvant cancer therapy
Showing 1 - 25 of >10,000
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)
Not yet recruiting
- Pancreas Cancer
- Pancreas Adenocarcinoma
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023
Radiotherapy, Breast Cancer, Relaxation Trial in Munich (Respiratory training and relaxation techniques under adjuvant radiation
Recruiting
- Radiotherapy
- +3 more
- Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
-
Munich, GermanyDepartment of Radiation Oncology, Technical University of Munich
Aug 1, 2023
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023
HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)
Not yet recruiting
- HR+/HER2-breast Cancer
- Standard endocrine therapy plus Apatinib
- (no location specified)
Jun 2, 2023
Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)
Recruiting
- Serplulimab,Gastric Cancer, Adjuvant Therapy
- Serplulimab
- +2 more
-
Shanghai, ChinaZhang Zizhen
Mar 3, 2023
Cervical Cancer Trial in Suzhou (Chemoradiotherapy + Adjuvant chemo and Zimberelimab, Chemoradiotherapy (small pelvic) +
Recruiting
- Cervical Cancer
- Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab
- Chemoradiotherapy (small pelvic) + Zimberelimab
-
Suzhou, Jiangsu, ChinaThe Affiliated Suzhou Hospital of Nanjing Medical University
May 14, 2023
Early-stage Breast Cancer Trial in Brno (APBI, WBI)
Completed
- Early-stage Breast Cancer
- APBI
- WBI
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Aug 17, 2023
Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)
Not yet recruiting
- Neoplasms
- +5 more
- Nivolumab
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2023
Anaplastic Thyroid Cancer Trial in Leiden (dabrafenib/trametinib)
Recruiting
- Anaplastic Thyroid Cancer
-
Leiden, Zuid-Holland, NetherlandsEllen Kapiteijn
Oct 5, 2023
Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Chemotherapy Effect
- FOLFOX chemotherapy regimens
- Bevacizumab
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023
Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)
Not yet recruiting
- Breast Cancer
- Ovarian Function Suppression + Aromatase Inhibitor
- Adjuvant Chemotherapy + Ovarian Function Suppression
- (no location specified)
May 19, 2023
Node-positive Breast Cancer Trial (Targeted axillary lymph node dissection)
Not yet recruiting
- Node-positive Breast Cancer
- Targeted axillary lymph node dissection
- (no location specified)
Jan 6, 2023
Lung Cancer Trial in Shanghai (Biopsy (baseline), Biopsy (optional, after treatment), Biopsy (optional, relapse and metastasis))
Not yet recruiting
- Lung Cancer
- Biopsy (baseline)
- +2 more
-
Shanghai, ChinaShanghai Pulmonary Hospital
May 11, 2023
INnovative and Micro-INvasive TEchniques for Early
Recruiting
- Breast Cancer
- Liquid biopsy and imaging
-
Aviano, Pordenone, ItalyCentro di Riferimento Oncologico
Apr 26, 2023
Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide combined with fulvestrant)
Not yet recruiting
- Hormone Receptor-positive Advanced Breast Cancer
- chidamide combined with fulvestrant
- (no location specified)
Mar 28, 2023
Breast Tumors, Breast Cancer Trial (PACHA Program)
Not yet recruiting
- Breast Neoplasms
- Breast Cancer
- PACHA Program
- (no location specified)
Jun 6, 2023
After Pancreatic Resection for Pancreatic Cancer
Recruiting
- Pancreatic Malignant Neoplasm Primary
-
Verona, ItalyUniversity of Verona Hospital
Nov 1, 2022
Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)
Not yet recruiting
- Endometrial Cancer
- Vaginal brachytherapy
- +2 more
- (no location specified)
Nov 29, 2022
NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)
Recruiting
- Non-small Cell Lung Cancer
- SH-1028 tablets
- Placebo SH-1028 tablets
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 6, 2023
HER2-positive Breast Cancer Trial (Standard of Care Adjuvant Breast Radiation, Standard of Care HER2-targeted Therapy Without
Not yet recruiting
- HER2-positive Breast Cancer
- Standard of Care Adjuvant Breast Radiation
- Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
- (no location specified)
Jan 20, 2023
Therapeutic Mammoplasty on the Start of Adjuvant Chemotherapy
Completed
- Effect of Therapeutic Mammoplasty on Adjuvant Chemotherapy
- therapeutic mammoplasty
- (no location specified)
Jun 16, 2023
Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)
Recruiting
- Stage II-III Gastric Cancer
- MRD-guided therapy
-
Jinan, Shandong, China
- +4 more
Nov 27, 2023